// App-Quantinova.ai

1515 : Cancer susceptibility mutations in individuals with breast and ovarian cancer using next-generation sequencing.

Researchers

Presenter

  • Kenneth Offit

Principal Investigators

  • Kara Noelle Maxwell

  • Joseph Vijai

  • Steven Hart

  • Tinu Thomas

  • Bradley Wubbenhorst

  • Vignesh Ravichandran

  • Raymond Moore

  • Chunling Hu

  • Jenna Lilyquist

  • Hermela Shimelis

  • Thomas Paul Slavin

  • Susan M. Domchek

  • Mark E. Robson

  • Csilla Szabo

  • Susan L. Neuhausen

  • Jeffrey N. Weitzel

  • Fergus J. Couch

  • Katherine L. Nathanson

Medical Centers

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • BC Cancer Agency, Vancouver, BC, Canada

  • University of Pennsylvania Perelman School of Medicine, Philadelphia, PA

  • Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer, New York, NY

  • Mayo Clinic, Rochester, MN

  • City of Hope, Duarte, CA

  • National Institute of Health, Bethesda, MD

  • Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Ovarian cancer

Biomarkers

  • Breast cancer type 1 susceptibility protein

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved